SARS-CoV-2 strains have made an appearance across the
globe, causing
over 757 million cases and over 6.85 million deaths at the time of
writing. The emergence of these variants shows the amplitude of genetic
variation to which the wild-type strains have been subjected. The
rise of the different SARS-CoV-2 variants resulting from such genetic
modification has significantly affected COVD-19’s major impact
on proliferation, virulence, and clinics. With the emergence of the
variants of concern, the spike protein has been identified as a possible
therapeutic target due to its critical role in binding to human cells
and pathogenesis. These mutations could be linked to functional heterogeneity
and use a different infection strategy. For example, the Omicron variant’s
multiple mutations should be carefully examined, as they represent
one of the most widely spread strains and hint to us that there may
be more genetic changes in the virus. As a result, we applied a common
protocol where we reconstructed SARS-CoV-2 variants of concern and
performed molecular dynamics simulations to study the stability of
the ACE2–RBD complex in each variant. We also carried out free
energy calculations to compare the binding and biophysical properties
of the different SARS-CoV-2 variants when they interact with ACE2.
Therefore, we were able to obtain consistent results and uncover new
crucial residues that were essential for preserving a balance between
maintaining a high affinity for ACE2 and the capacity to evade RBD-targeted
antibodies. Our detailed structural analysis showed that SARS-CoV-2
variants of concern show a higher affinity for ACE2 compared to the
Wuhan strain. Additionally, residues K417N and E484K/A might play
a crucial role in antibody evasion, whereas Q498R and N501Y are specifically
mutated to strengthen RBD affinity to ACE2 and, thereby, increase
the viral effect of the COVID-19 virus.